Key Details
Annual ROE
-69.76%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 03, 2024Recent annual earnings:
Mar 11, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with NGM included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Similar stocks
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that two abstracts highlighting clinical data from the ongoing Phase 1/2 clinical trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, have been selected for presentation at the American Association for Cancer Research (AACR) Annual Meeting, being held April 5-10, 2024 in San Diego, CA.
NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.45 per share a year ago.
NGM Biopharmaceuticals (NGM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.59 per share a year ago.
NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.46 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.59 per share a year ago.
SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at the following upcoming investor conferences.
FAQ
- What is the primary business of NGM Biopharmaceuticals?
- What is the ticker symbol for NGM Biopharmaceuticals?
- Does NGM Biopharmaceuticals pay dividends?
- What sector is NGM Biopharmaceuticals in?
- What industry is NGM Biopharmaceuticals in?
- What country is NGM Biopharmaceuticals based in?
- When did NGM Biopharmaceuticals go public?
- Is NGM Biopharmaceuticals in the S&P 500?
- Is NGM Biopharmaceuticals in the NASDAQ 100?
- Is NGM Biopharmaceuticals in the Dow Jones?
- When was NGM Biopharmaceuticals's last earnings report?
- When does NGM Biopharmaceuticals report earnings?
- Should I buy NGM Biopharmaceuticals stock now?